Search
NCI National Cancer Institute: Manufacturing CAR T Cells to Accelerate Cancer Immunotherapy Research
- Patient Education: Video
- Jun 26, 2021
- 1 min read
Updated: Apr 7, 2022
NCI National Cancer Institute: Manufacturing CAR T Cells to Accelerate Cancer Immunotherapy Research
Manufacturing CAR T Cells to Accelerate Cancer Immunotherapy Research
An example of CART Cell therapy approved by FDA to treat relapsed & refractory Multiple Myeloma is